J-113,397 is an
opioid
Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use ...
drug which was the first compound found to be a highly selective antagonist for the
nociceptin receptor
The nociceptin opioid peptide receptor (NOP), also known as the nociceptin/orphanin FQ (N/OFQ) receptor or kappa-type 3 opioid receptor, is a protein that in humans is encoded by the ''OPRL1'' (opioid receptor-like 1) gene. The nociceptin receptor ...
, also known as the ORL-1 receptor. It is several hundred times selective for the ORL-1 receptor over other opioid receptors, and its effects in animals include preventing the development of
tolerance to
morphine
Morphine is a strong opiate that is found naturally in opium, a dark brown resin in poppies (''Papaver somniferum''). It is mainly used as a pain medication, and is also commonly used recreationally, or to make other illicit opioids. T ...
, the prevention of
hyperalgesia
Hyperalgesia ( or ; 'hyper' from Greek ὑπέρ (huper, “over”), '-algesia' from Greek algos, ἄλγος (pain)) is an abnormally increased sensitivity to pain, which may be caused by damage to nociceptors or peripheral nerves and can ...
induced by intracerebroventricular administration of
nociceptin (orphanin FQ), as well as the stimulation of
dopamine release in the
striatum, which increases the rewarding effects of
cocaine
Cocaine (from , from , ultimately from Quechua: ''kúka'') is a central nervous system (CNS) stimulant mainly used recreationally for its euphoric effects. It is primarily obtained from the leaves of two Coca species native to South Ameri ...
, but may have clinical application in the treatment of
Parkinson's disease
Parkinson's disease (PD), or simply Parkinson's, is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms becom ...
.
Synthesis
Patents for treating
arrhythmia:
[Guo Zheng, et al. & (2020).]
Condensation between 1-Benzyl-3-methoxycarbonyl-4-piperidone
7611-47-9(1) and
O-Phenylenediamine
''o''-Phenylenediamine (OPD) is an organic compound with the formula C6H4(NH2)2. This aromatic diamine is an important precursor to many heterocyclic compounds. It is isomeric with ''m''-phenylenediamine and ''p''-phenylenediamine.
Preparation ...
(2) give
CID:16726310(3). Reaction with
boc anhydride
Di-''tert''-butyl dicarbonate is a reagent widely used in organic synthesis. Since this compound can be regarded formally as the acid anhydride derived from a ''tert''-butoxycarbonyl (Boc) group, it is commonly referred to as Boc anhydride. This ...
followed by treatment with
trifluoroacetic acid
Trifluoroacetic acid (TFA) is an organofluorine compound with the chemical formula CF3CO2H. It is a structural analogue of acetic acid with all three of the acetyl group's hydrogen atoms replaced by fluorine atoms and is a colorless liquid with ...
give
CID:16726358(4). Reaction with
iodoethane
Ethyl iodide (also iodoethane) is a colorless flammable chemical compound. It has the chemical formula C2H5I and is prepared by heating ethanol with iodine and phosphorus.''Merck Index of Chemicals and Drugs'', 9th ed., monograph 3753 On contact ...
in the presence of base alkylates the urea nitrogen givin
CID:16726359(5). Reduction of the enamine by treatment with magnesium metal in methanol solvent occurs to give predominantly the trans isomer
CID:16726360(6). Catalytic removal of the benzyl group give
CID:16726362(7). Reductive amination with Cyclooctanecarbaldehyde
688-11-5(7) give
CID:16726364(9). Lastly, reduction of the ester with lithium aluminium hydride completed the synthesis of J-113397 (10).
See also
*
JTC-801
*
LY-2940094
BTRX-246040, also known as LY-2940094, is a potent and selective nociceptin receptor antagonist which is under development by BlackThorn Therapeutics and Eli Lilly for the treatment of major depressive disorder (MDD). It has demonstrated proof ...
*
SB-612,111
Trap-101(unsaturated olefin not reduced).
References
{{Opioidergics
Synthetic opioids
Benzimidazoles
Piperidines
Ureas
Primary alcohols
Nociceptin receptor antagonists